Coccidioidomycosis in renal replacement therapy

I. M. Cohen, J. N. Galgiani, D. Potter, D. A. Ogden

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

The potential risk of coccidioidomycosis has led to concern about the advisability of maintaining renal transplantation programs in endemic areas. We reviewed the charts of 721 patients undergoing dialysis and 260 renal transplant recipients in Arizona to determine the incidence, risk factors, and clinical course of coccidioidomycosis in these immunosuppressed populations. Symptomatic infection occurred in six (0.83%) patients undergoing dialysis and 18 (6.9%) transplant recipients. Male sex and blood type B predisposed to dissemination. Urine cultures for fungus were important diagnostic aids. Four of six patients with infection limited to the thorax and five of 18 patients with dissemination remained alive after seven months to 7 1/2 years. Although the rate of dissemination (75%) and mortality (63%) from coccidioidomycosis were high, the incidence of infection was low and does not preclude renal transplantation in Arizona. Those who have received transplants elsewhere should be advised not to move to or visit areas endemic for coccidioidomycosis.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalArchives of Internal Medicine
Volume142
Issue number3
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Coccidioidomycosis
Renal Replacement Therapy
Kidney Transplantation
Infection
Incidence
Renal Dialysis
Dialysis
Fungi
Thorax
Urine
Transplants
Mortality
Population
Transplant Recipients

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Cohen, I. M., Galgiani, J. N., Potter, D., & Ogden, D. A. (1982). Coccidioidomycosis in renal replacement therapy. Archives of Internal Medicine, 142(3), 489-494. https://doi.org/10.1001/archinte.142.3.489

Coccidioidomycosis in renal replacement therapy. / Cohen, I. M.; Galgiani, J. N.; Potter, D.; Ogden, D. A.

In: Archives of Internal Medicine, Vol. 142, No. 3, 1982, p. 489-494.

Research output: Contribution to journalArticle

Cohen, IM, Galgiani, JN, Potter, D & Ogden, DA 1982, 'Coccidioidomycosis in renal replacement therapy', Archives of Internal Medicine, vol. 142, no. 3, pp. 489-494. https://doi.org/10.1001/archinte.142.3.489
Cohen, I. M. ; Galgiani, J. N. ; Potter, D. ; Ogden, D. A. / Coccidioidomycosis in renal replacement therapy. In: Archives of Internal Medicine. 1982 ; Vol. 142, No. 3. pp. 489-494.
@article{27c87223bc4847d9ba899f59510eb6c9,
title = "Coccidioidomycosis in renal replacement therapy",
abstract = "The potential risk of coccidioidomycosis has led to concern about the advisability of maintaining renal transplantation programs in endemic areas. We reviewed the charts of 721 patients undergoing dialysis and 260 renal transplant recipients in Arizona to determine the incidence, risk factors, and clinical course of coccidioidomycosis in these immunosuppressed populations. Symptomatic infection occurred in six (0.83{\%}) patients undergoing dialysis and 18 (6.9{\%}) transplant recipients. Male sex and blood type B predisposed to dissemination. Urine cultures for fungus were important diagnostic aids. Four of six patients with infection limited to the thorax and five of 18 patients with dissemination remained alive after seven months to 7 1/2 years. Although the rate of dissemination (75{\%}) and mortality (63{\%}) from coccidioidomycosis were high, the incidence of infection was low and does not preclude renal transplantation in Arizona. Those who have received transplants elsewhere should be advised not to move to or visit areas endemic for coccidioidomycosis.",
author = "Cohen, {I. M.} and Galgiani, {J. N.} and D. Potter and Ogden, {D. A.}",
year = "1982",
doi = "10.1001/archinte.142.3.489",
language = "English (US)",
volume = "142",
pages = "489--494",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Coccidioidomycosis in renal replacement therapy

AU - Cohen, I. M.

AU - Galgiani, J. N.

AU - Potter, D.

AU - Ogden, D. A.

PY - 1982

Y1 - 1982

N2 - The potential risk of coccidioidomycosis has led to concern about the advisability of maintaining renal transplantation programs in endemic areas. We reviewed the charts of 721 patients undergoing dialysis and 260 renal transplant recipients in Arizona to determine the incidence, risk factors, and clinical course of coccidioidomycosis in these immunosuppressed populations. Symptomatic infection occurred in six (0.83%) patients undergoing dialysis and 18 (6.9%) transplant recipients. Male sex and blood type B predisposed to dissemination. Urine cultures for fungus were important diagnostic aids. Four of six patients with infection limited to the thorax and five of 18 patients with dissemination remained alive after seven months to 7 1/2 years. Although the rate of dissemination (75%) and mortality (63%) from coccidioidomycosis were high, the incidence of infection was low and does not preclude renal transplantation in Arizona. Those who have received transplants elsewhere should be advised not to move to or visit areas endemic for coccidioidomycosis.

AB - The potential risk of coccidioidomycosis has led to concern about the advisability of maintaining renal transplantation programs in endemic areas. We reviewed the charts of 721 patients undergoing dialysis and 260 renal transplant recipients in Arizona to determine the incidence, risk factors, and clinical course of coccidioidomycosis in these immunosuppressed populations. Symptomatic infection occurred in six (0.83%) patients undergoing dialysis and 18 (6.9%) transplant recipients. Male sex and blood type B predisposed to dissemination. Urine cultures for fungus were important diagnostic aids. Four of six patients with infection limited to the thorax and five of 18 patients with dissemination remained alive after seven months to 7 1/2 years. Although the rate of dissemination (75%) and mortality (63%) from coccidioidomycosis were high, the incidence of infection was low and does not preclude renal transplantation in Arizona. Those who have received transplants elsewhere should be advised not to move to or visit areas endemic for coccidioidomycosis.

UR - http://www.scopus.com/inward/record.url?scp=0020058841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020058841&partnerID=8YFLogxK

U2 - 10.1001/archinte.142.3.489

DO - 10.1001/archinte.142.3.489

M3 - Article

C2 - 7039544

AN - SCOPUS:0020058841

VL - 142

SP - 489

EP - 494

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 3

ER -